{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_024652.4:c.4322C>T",
          "cDNA Change": {
            "transcript": "NM_024652.4",
            "ref": "C",
            "alt": "T",
            "position": "4322"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "C",
            "position": "1441"
          },
          "Description in input context": "R1441C"
        },
        {
          "HGVS": "NM_024652.4:c.6055G>A",
          "cDNA Change": {
            "transcript": "NM_024652.4",
            "ref": "G",
            "alt": "A",
            "position": "6055"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S"
        },
        {
          "HGVS": "NM_024652.4:c.6058A>C",
          "cDNA Change": {
            "transcript": "NM_024652.4",
            "ref": "A",
            "alt": "C",
            "position": "6058"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "T",
            "position": "2020"
          },
          "Description in input context": "I2020T"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson’s disease",
    "MONDO": "MONDO:0005148"
  },
  "Experiment Method": [
    {
      "Assay Method": "In vitro kinase assay",
      "Material used": {
        "Material Source": "Recombinant proteins",
        "Material Name": "Human Akt1 (His-tagged protein), Human LRRK2 (GST-tagged protein)",
        "Description": "One hundred nanograms of recombinant human Akt1 (His-tagged protein) was incubated with 50 ng of recombinant human LRRK2 [glutathione-S transferase (GST)-tagged protein consisting of amino acid residues 970–2527; either wildtype, R1441C mutant, G2019 mutant, or I2020T mutant]"
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_024652.4:c.4322C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "reduced interaction with, and phosphorylation of, Akt1",
          "Result Description": "The disease-associated mutation R1441C exhibited reduced interaction with, and phosphorylation of, Akt1."
        },
        {
          "Variant": "NM_024652.4:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "reduced interaction with, and phosphorylation of, Akt1",
          "Result Description": "The disease-associated mutation G2019S exhibited reduced interaction with, and phosphorylation of, Akt1."
        },
        {
          "Variant": "NM_024652.4:c.6058A>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "reduced interaction with, and phosphorylation of, Akt1",
          "Result Description": "The disease-associated mutation I2020T exhibited reduced interaction with, and phosphorylation of, Akt1."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "In vitro GST pull-down assay",
      "Material used": {
        "Material Source": "Recombinant proteins",
        "Material Name": "GST-LRRK2, His-Akt1",
        "Description": "Recombinant GST-LRRK2 or GST alone was mixed with the recombinant His-Akt1 and incubated with glutathione agarose beads"
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_024652.4:c.4322C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "impaired ability to bind Akt1",
          "Result Description": "The disease-associated mutation R1441C showed impaired ability to bind Akt1."
        },
        {
          "Variant": "NM_024652.4:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "impaired ability to bind Akt1",
          "Result Description": "The disease-associated mutation G2019S showed impaired ability to bind Akt1."
        },
        {
          "Variant": "NM_024652.4:c.6058A>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "impaired ability to bind Akt1",
          "Result Description": "The disease-associated mutation I2020T showed impaired ability to bind Akt1."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Western analysis",
      "Material used": {
        "Material Source": "Cell lysates",
        "Material Name": "Neuroblastoma SH-SY5Y cells",
        "Description": "Proteins after in vitro phosphorylation and those in cell lysates were subjected to SDS–PAGE"
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_024652.4:c.4322C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "reduced phosphorylation of Akt1 (Ser473)",
          "Result Description": "Knockdown of LRRK2 resulted in a marked reduction of phospho-Akt1 (Ser473) for the R1441C variant."
        },
        {
          "Variant": "NM_024652.4:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "reduced phosphorylation of Akt1 (Ser473)",
          "Result Description": "Knockdown of LRRK2 resulted in a marked reduction of phospho-Akt1 (Ser473) for the G2019S variant."
        },
        {
          "Variant": "NM_024652.4:c.6058A>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "reduced phosphorylation of Akt1 (Ser473)",
          "Result Description": "Knockdown of LRRK2 resulted in a marked reduction of phospho-Akt1 (Ser473) for the I2020T variant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "one-way ANOVA"
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}